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Transradial access (TRA) is becoming widely adopted by
interventional cardiologists around the world as the pre-
ferred access site for coronary diagnostic angiography and
interventions. Although it was initially described >20 years
ago, TRA adoption remained stagnant for a long time
despite zealous grassroots promotion by a small group of
aﬁcionados, as it was generally ignored by a large majority
of interventional cardiologists. Recently, several factors
have spawned growing popularity of TRA, including bet-
ter recognition of the detrimental impact of periprocedural
bleeding, the reduction of costs associated with the neu-
tralization of vascular complications and early hospital
discharge, and the overwhelming preference of patients.
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Modern medicine has moved from its traditional practice
as an art on the basis of unique interaction between practi-
tioner and patient to a practice guided by evidence-based
medicine supported by the results of clinical trials and
observational studies. Because of a lack of support from large
industry funding, it took a long time to perform randomized
clinical trials to establish the beneﬁts and safety of TRA
compared with the standard transfemoral approach. There is
now good evidence that shows substantial and drastic re-
ductions of vascular access complications and bleeding with
TRA after diagnostic angiography and interventions in all
clinical scenarios (1). More recent studies have even shown
reductions in early mortality with TRA for patients under-
going primary percutaneous coronary intervention, although
the extent and exact mechanisms of such beneﬁt remain
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become widely acknowledged, efforts should be directed so
that the radial artery (or the ulnar artery in some cases) be-
comes the default access site, with the femoral artery reserved
for bail-out access. Yet it must be recognized that TRA is
not always technically feasible, so that even in experienced
hands, primary failure or crossovers to the femoral approach
may still occur (3). For that reason, optimal access-site
management in general and judicious selection of antith-
rombotic regimens in particular for the femoral approach
remain paramount.
The types of patients to whom TRA should be eventually
denied remain a hot topic, and the issue of using or not
the Allen test (AT) before undertaking TRA is probably
one of the most important. The main controversy with the
use of the subjective AT, or the more objective method of
oximetry-plethysmography, is to evaluate whether those tests
can reliably predict signiﬁcant ischemic risk for the hand,
presumably due to periprocedural radial artery occlusion
(RAO).
Although acute RAO has been described since the initial
description of TRA, its clinical relevance remains contro-
versial. In a recent international survey among radial opera-
tors, the incidence of RAO at hospital discharge was not
assessed in 50% of cases (4). Although RAO has been
documented in up to 30% of patients after transradial cath-
eterization, it is a common clinical observation that RAO
remains asymptomatic in the large majority of patients. In
contrast, it should be recalled that acute limb ischemia has
been reported in up to 2% of patients after periprocedural
femoral artery occlusion (5). Reports of leg amputation after
transfemoral catheterization exist, and death can occur,
directly resulting from femoral artery injuries or retroperi-
toneal bleeding. To date, no hand or ﬁnger amputation has
been reported after TRA for diagnostic angiography or
intervention, even though TRA has been used worldwide for
>20 years (6). It is obvious that the generous and redundant
vascularization of the hand by the radial, ulnar, and inter-
osseous arteries provides protection against distal ischemia in
case of RAO after catheterization (Fig. 1). This does not
guarantee that distal ﬁnger ischemia or gangrene cannot
occur after radial artery manipulation. However, in most
cases of distal ischemia reported in the published data, AT
results were considered normal before the procedure, and
angiographic ﬁndings revealed distal embolization in addi-
tion to RAO (7).
In the RADAR (Should Intervention Through Radial
Approach be Denied to Patients With Negative Allen’s Test
Results?) study, reported in this issue of the Journal, Valgi-
migli et al. (8) studied the relationship between functional
assessment of dual-artery circulation to the hand (using the
AT and plethysmography-oximetry) and measures of distal
ischemia (lactate), collateralization between the radial and
ulnar arteries (ulnar frame count), and strength and
discomfort of the hand after TRA. Although their cathe-
terization laboratory is a radial-ﬁrst laboratory, and they
Figure 1 Example of Large Vascularization of the Hand
Figure permission from Gunther von Hagens’ BODY WORLDS, Institute
for Plastination, Heidelberg, Germany.
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patients (22%) were ultimately recruited and completed the
study. AT results were categorized as normal in 40%, in-
termediate in 30%, and abnormal in 30% of the patients.
This means that in a typical patient group referred for
elective catheterization, 60% of patients had mean time to
recolor the skin of 6 s after releasing ulnar artery
compression and maintaining occlusion of the radial artery.
Conversely, the D pattern after plethysmography-oximetry,
thought to indicate poor collateralization between the
vascular palmar arches, was found in 40% of the patients, but
only in those with abnormal AT results. This indicates that
in patients referred for coronary angiography, compression
of the radial artery while keeping the ulnar artery patent
will lead to very variable results in terms of timing to the
subjective assessment of skin coloration or the more objec-
tive reading of oximetry-plethysmography curves. Further-
more, there was a weak correlation between the 2 tests. The
investigators also noted large variability over time in the
oximetry-plethysmography curves.
What is the impact of these pre-tests on ischemia, angi-
ography, and the function of the hand during and after
transradial catheterization? First, the investigators nicely
demonstrate that the capillary lactate measured at the thumblevel (the primary end point) immediately after the proce-
dure and up to 1 year later remained independent of the
results of the AT or oximetry-plethysmography. Second, it is
remarkable that the lactate levels in patients with abnormal
AT results were virtually identical to those in a previously
published Canadian study in which operators occluded
the radial artery for 30 min with a clamp. Importantly, it
must be noted that the levels of lactate during or after these
occlusive tests of the radial artery remained in normal range
(9). Furthermore, it is worth observing that higher lactate
levels were measured during the hemostasis period than
during the period when the sheaths were in place. On the
basis of this study, it is reassuring, although not surprising,
that transradial catheterization does not induce an elevation
in lactate levels, even in patients with persistent RAO.
For the ﬁrst time, Valgimigli et al. (8) have studied ulnar
frame count on the basis of the technique developed by the
Thrombolysis In Myocardial Infarction group (the lower the
frame count, the better). Although it must be acknowledged
that the ulnar frame count may vary according to proximal as
well as distal vasculature changes, the investigators did
observe a number of meaningful changes. Before the pro-
cedure (after radial sheath insertion), ulnar frame counts
were signiﬁcantly higher, in accordance with AT results.
Yet the range of values in patients with abnormal AT results
was wider than in those with normal and intermediate AT
results. At the completion of the study (about 1 h later),
ulnar frame counts decreased in all patients, albeit with
signiﬁcant reductions only in patients with abnormal AT
results. This may indirectly suggest that proximal or distal
collateral vessels were recruited, especially in patients with
abnormal AT results, because ulnar frame count is per-
formed when RAO is produced by the radial sheath.
Most important, the investigators also performed func-
tional testing of the hand. Using a handgrip strength test,
they did not ﬁnd any difference according to AT results, and
strength remained stable or slightly increased in all groups
over time. Finally, on the basis of visual analogue scale
ratings, discomfort in the hand was moderately increased
during the transradial catheterization and hemostasis phase,
but it almost disappeared after 24 h, with no residual
discomfort up to 1 year later. Again, no relationship with
AT or oximetry-plethysmography results was noted.
From this carefully performed mechanistic study, one
can conclude that the AT and oximetry-plethysmography
are not reliable tests to predict distal ischemia, loss of
strength, or discomfort after transradial catheterization. In
the context of the privileged relationship between the
cardiologist and the patient, or from a legal point of view, it
is more important to discuss the relative beneﬁts and risks of
radial access compared with femoral access for diagnostic
angiography and intervention. Ultimately, the selection of
femoral versus radial access site should take into account the
potentially life-threatening femoral complications compared
with the less severe radial complications. Moreover, on the
basis of current evidence-based medicine, concerted efforts
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to reduce the risks of periprocedural RAO, not from the fear
of distal complications but because chronic RAO hampers
future use of the radial artery as a repeat access site (10).
On the basis of the results of RADAR, we believe that
the denial of radial access for diagnostic angiography or
interventions solely on the basis of an abnormal AT or
oximetry-plethysmography curve is not warranted, because
these tests are not scientiﬁcally predictive of pathologic
rises in lactate levels, weakness in the hand, or persistent
discomfort during or after transradial catheterization. The
time has come to remove the AT from pre-procedural triage
for transradial catheterization. We need to refocus our
attention on the use of oximetry-plethysmography and other
techniques to guide “patent hemostasis” once the transradial
procedure is completed to minimize RAO (11,12).
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